Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Horowski · SciRah

Researcher profile · Semantic Scholar

R. Horowski

Share profile

R. Horowski — researcher profile on SciRah

h-index: 21
Works: 153
Citations: 1,830

Most-cited papers

High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study
M. Graf, D. Ecker, R. Horowski, B. Kramer +27 more
2005Journal of neural transmission195 citations
Semantic Scholar
Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis
C. Hofmann, U. Penner, R. Dorow, H. Pertz +5 more
2006Clinical neuropharmacology105 citations
Semantic Scholar
Agonism at 5-HT2B receptors is not a class effect of the ergolines.
S. Jähnichen, R. Horowski, H. Pertz
2005European Journal of Pharmacology97 citations
Semantic Scholar
The role of pulsatile versus continuous dopamine receptor stimulation for functional recovery in Parkinson's disease.
J. Obeso, F. Grandas, M. Herrero, R. Horowski
1994European Journal of Neuroscience86 citations
Semantic Scholar
An Essay on Wilhelm von Humboldt and the Shaking Palsy
R. Horowski, L. Horowski, C. Phil, S. Vogel +2 more
1995Neurology46 citations
Semantic Scholar
The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates
K. Lange, P. Löschmann, E. Sofić, M. Burg +4 more
1993Naunyn-Schmiedeberg's Archives of Pharmacology40 citations Open access
Semantic Scholar
Transdermal lisuride delivery in the treatment of Parkinson's disease.
D. Woitalla, T. Müller, S. Benz, R. Horowski +1 more
2004Journal of neural transmission. Supplementum37 citations
Semantic Scholar
Fibrotic valvular heart disease is not related to chemical class but to biological function: 5‐HT2B receptor activation plays crucial role
R. Horowski, S. Jähnichen, Heinz H. Pertz
2004Movement Disorders31 citations
Semantic Scholar
Anxiogenic, not psychotogenic, properties of the partial inverse benzodiazepine receptor agonist FG 7142 in man
R. Horowski, R. Dorow
2002Psychopharmacology29 citations
Semantic Scholar
Pharmacological properties of a wide array of ergolines at functional alpha1-adrenoceptor subtypes
T. Görnemann, S. Jähnichen, B. Schurad, K. Latté +4 more
2007Naunyn-Schmiedeberg's Archives of Pharmacology28 citations
Semantic Scholar
Lisuride plus selegiline in the treatment of early Parkinson's disease
G. Nappi, E. Martignoni, R. Horowski, C. Pacchetti +3 more
1991Acta Neurologica Scandinavica20 citations Open access
Semantic Scholar
Characterization of the Molecular Fragment That Is Responsible for Agonism of Pergolide at Serotonin 5-Hydroxytryptamine2B and 5-Hydroxytryptamine2A Receptors
T. Görnemann, H. Hübner, P. Gmeiner, R. Horowski +3 more
2008Journal of Pharmacology and Experimental Therapeutics19 citations
Semantic Scholar
L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
P. Riederer, R. Horowski
2023Journal of neural transmission17 citations Open access
Semantic Scholar
Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo.
E. Martignoni, R. Horowski, A. Liuzzi, Alfredo Costa +5 more
1996Clinical neuropharmacology17 citations
Semantic Scholar
Continuous dopaminergic stimulation: state of the art and outlook.
R. Horowski, C. Marsden, J. Obeso
1988Journal of neural transmission. Supplementum17 citations
Semantic Scholar
Classical dopamine agonists
R. Horowski, P. Löschmann
2019Journal of neural transmission16 citations Open access
Semantic Scholar
Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets.
K. Lange, P. Löschmann, H. Wachtel, R. Horowski +3 more
1992European Journal of Pharmacology15 citations Open access
Semantic Scholar
Can we differentiate symptomatic and neuroprotective effects in parkinsonism? The dopamine agonist lisuride delays the need for levodopa therapy to a similar extent as reported for deprenyl.
I. Runge, R. Horowski
1991Journal of Neural Transmission - Parkinsons Disease and Dementia Section14 citations
Semantic Scholar
Possible role of gonadal hormones as triggering factors in migraine.
R. Horowski, I. Runge
1986Functional Neurology13 citations
Semantic Scholar
A history of dopamine agonists. From the physiology and pharmacology of dopamine to therapies for prolactinomas and Parkinson’s disease – a subjective view
R. Horowski
2006Journal of neural transmission12 citations
Semantic Scholar
Lisuride Pharmacology and Treatment of Parkinson’s Disease
G. Gopinathan, R. Horowski, I. Suchy
198912 citations
Semantic Scholar
Parenteral administration of lisuride in Parkinson's disease.
M. Luquin, J. Obeso, J. Martínez-Lage, J. Tresguerres +4 more
1987Advances in neurology12 citations
Semantic Scholar
IBZM-SPECT imaging in Parkinson's disease. Quantification of binding ratios from sequential SPECT measurements in patients and controls.
M. Cordes, J. Hierholzer, L. Schelosky, Werner Poewe +5 more
1993Advances in neurology11 citations
Semantic Scholar
Possible Pharmacological Mechanisms of Chronic Abuse of Analgesics and Other Antimigraine Drugs
R. Horowski, A. Ziegler
198810 citations
Semantic Scholar
Lisuride and bromocryptine in L-Dopa stable-responder parkinsonian patients: a comparative, double-blind evaluation of cardiopressor and neurochemical effects.
G. Micieli, E. Martignoni, Anna Cavallini, C. Pacchetti +3 more
1996Functional Neurology9 citations
Semantic Scholar
[The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].
J. Hierholzer, M. Cordes, L. Schelosky, G. Barzen +5 more
1992RöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (Print)9 citations
Semantic Scholar
Striatal plasticity and motor learning-importance of circadian rhythms, sleep stages and dreaming....
R. Horowski, H. Benes̆, K. Fuxe
2004Parkinsonism & Related Disorders8 citations
Semantic Scholar
From Wilhelm von Humboldt to Hitler-are prominent people more prone to have Parkinson's disease?
R. Horowski, L. Horowski, S. M. Calne, D. Calne
2000Parkinsonism & Related Disorders8 citations
Semantic Scholar
Differentialdiagnose der Parkinson-Erkrankungen - 123I-IBZM-SPECT vs. Apomorphin-Test
J. Hierholzer, M. Cordes, L. Schelosky, B. Sander +4 more
19938 citations
Semantic Scholar
Antagonist effect of terguride in Parkinson's disease.
S. Ruggieri, F. Stocchi, F. Baronti, F. Viselli +3 more
1991Clinical neuropharmacology8 citations
Semantic Scholar
Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson's disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptors.
B. Schurad, R. Horowski, S. Jähnichen, T. Görnemann +2 more
2006Life Science7 citations
Semantic Scholar
Suppression of puerperal lactation by terguride. A double-blind study.
P. Venturini, R. Horowski, V. Fasce, M. Valenzano +5 more
1988Gynecologic and Obstetric Investigation7 citations
Semantic Scholar
Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.
H. Stracke, W. Heinlein, R. Horowski, H. Schatz
1986Arzneimittel-Forschung7 citations
Semantic Scholar
Dependence liability of lormetazepam: are all benzodiazepines equal? The case of the new i.v. lormetazepam for anesthetic procedures
R. Horowski
2020Journal of neural transmission6 citations Open access
Semantic Scholar
[The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test].
J. Hierholzer, M. Cordes, L. Schelosky, B. Sander +4 more
1993RöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (Print)6 citations
Semantic Scholar
Transdermal lisuride delivery in the treatment of Parkinson?s disease
D. Woitalla, T. Mller, S. Benz, R. Horowski +1 more
20035 citations
Semantic Scholar
Multiple sclerosis and interferon β-1b, past, present and future
R. Horowski
20025 citations
Semantic Scholar
FG 7142: is this validated tool to study anxiety now forgotten?
R. Horowski
2020Journal of neural transmission4 citations
Semantic Scholar
Effect of terguride on prolactin levels in normal, puerperal and hyperprolactinaemic women
Pier Luigi Venturini, R. Horowski, M. Valenzano, Sergio Costantini +4 more
2004European Journal of Clinical Pharmacology4 citations
Semantic Scholar
Interferon β‐1b in Multiple Sclerosis
B. Aufdembrinke, R. Horowski, J. Kapp
20004 citations
Semantic Scholar
BROMERGURIDE ‐ AN ERGOLINE DERIVATIVE WITH ATYPICAL NEUROLEPTIC PROPERTIES
P. Löschmann, R. Horowski, H. Wachtel
1992Clinical neuropharmacology4 citations
Semantic Scholar
A study of the cardiopressor effects of lisuride in the treatment of parkinsonism and pathological aging brain.
G. Micieli, E. Martignoni, G. Bono, Anna Cavallini +3 more
1989Clinical neuropharmacology4 citations
Semantic Scholar
Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis.
R. Horowski, C. Stürzebecher, J. Kapp
2001Functional Neurology3 citations
Semantic Scholar
Bestimmung der zerebralen Dopamin–(D2)–Rezeptoren–Dichte mit Hilfe der123 Jod–IBZM–SPECT bei Patienten mit Morbus Parkinson
J. Hierholzer, M. Cordes, L. Schelosky, G. Barzen +5 more
19923 citations
Semantic Scholar
International Workshop Berlin Parkinson's Disease, January 30 - February 1, 1991 : how to proceed today in treatment : from basic research and early diagnosis to long-term treatment
U. Rinne, T. Nagatsu, R. Horowski
19913 citations
Semantic Scholar
Lisuride: An 8-Alpha-Ergoline with Ergot Antagonistic Properties
R. Horowski
2021NeuroPsychopharmacotherapy2 citations
Semantic Scholar
Japanese medicine and Berlin: a very special and successful relationship
R. Horowski
2017Journal of neural transmission2 citations
Semantic Scholar
Multiple sclerosis and interferon beta-1b, past, present and future.
R. Horowski
2002Clinical neurology and neurosurgery (Dutch-Flemish ed. Print)2 citations
Semantic Scholar
CNS research in the pharmaceutical industry
R. Horowski
2004European Journal of Clinical Pharmacology1 citations
Semantic Scholar
Immunotherapy of multiple sclerosis--current status and future perspectives. September 15, 1984, Zurich, Switzerland. Abstracts.
M. Ryba, K. Johansson, A. Cybulska, F. Patti +35 more
2004European Neurology1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Pertz×5
Invite
H. Pertz — researcher profile on SciRah
S. Jähnichen×5
Invite
S. Jähnichen — researcher profile on SciRah
W. Poewe×5
Invite
W. Poewe — researcher profile on SciRah
E. Martignoni×5
Invite
E. Martignoni — researcher profile on SciRah

×5

Invite

J. Hierholzer — researcher profile on SciRah

P. Löschmann×4

Invite

P. Löschmann — researcher profile on SciRah

Invite

G. Nappi — researcher profile on SciRah

Invite

E. Rainer — researcher profile on SciRah

L. Schelosky×4

Invite

L. Schelosky — researcher profile on SciRah

Invite

R. Dorow — researcher profile on SciRah

Invite

K. Latté — researcher profile on SciRah

Invite

B. Schurad — researcher profile on SciRah